Viral Pneumonia

Subscribe to Selected New Research on Viral Pneumonia

118 relevant articles (3 outcomes, 8 trials/studies) found for this Disease

Description: Inflammation of the lung parenchyma that is caused by a viral infection.

Also Known As:

Pneumonia, Viral; Pneumonias, Viral; Viral Pneumonias

Relationship Network

Disease Context: Research Results

Virus Diseases: 1376

Viral Pneumonia: 118

Respiratory Tract Diseases: 377

Lung Diseases: 8942

Pneumonia: 17859

Viral Pneumonia: 118

Respiratory Tract Infections: 5595

Pneumonia: 17859

Viral Pneumonia: 118

Related Diseases

1.	Infection
2.	Paramyxoviridae Infections (Parainfluenza)
3.	Bacterial Pneumonia
4.	Severe Combined Immunodeficiency (SCID)
5.	Virus Diseases (Viral Diseases)

Experts

1.	Godwin, J David: 1 article (08/2007)
2.	Escuissato, Dante L: 1 article (08/2007)
3.	Kanne, Jeffrey P: 1 article (08/2007)
4.	Franquet, Thomás: 1 article (08/2007)
5.	Müller, Nestor L: 1 article (08/2007)
6.	Nuutila, Jari: 1 article (01/2006)
7.	Nikoskelainen, Jukka: 1 article (01/2006)
8.	Lilius, Esa-Matti: 1 article (01/2006)
9.	Kotilainen, Pirkko: 1 article (01/2006)
10.	Laitinen, Iina: 1 article (01/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Viral Pneumonia:

1.	Ribavirin (Virazole)FDA LinkGeneric 11/05/1988 - "Nebulised ribavirin for influenza B viral pneumonia in a ventilated immunocompromised adult." 09/01/1993 - "Clinically, ribavirin has been used effectively in persons primarily to treat life-threatening viral diseases such as acute haemorrhagic fever or viral pneumonia of infants. " 03/01/1986 - "Viral infections, particularly viral pneumonia, are often life-threatening in infants with severe combined immunodeficiency disease (SCID), and ribavirin aerosol has been used successfully to treat respiratory syncytial virus and parainfluenza virus infection of immunodeficient children. " 11/15/1990 - "Fortunately, viral pneumonias usually resolve without specific antiviral therapy; however, ribavirin is indicated for respiratory syncytial virus pneumonia in children and ganciclovir sodium (Cytovene) for cytomegalovirus pneumonia in immunocompromised patients. " Order ALL the reference details at left...
2.	Complement System Proteins (Complement)IBA 06/25/1976 - "401 cases of viral pneumonia diagnosed between January 1973 and August 1975 were investigated serologically by the complement-fixation test. " 01/01/1984 - "Marked decrease in the content of complement and beta-lysins, elevation of the level of lysozyme were observed in patients with viral-bacterial and viral pneumonias as compared to the same characteristics in patients with bacterial pneumonia and in control group subjects." 04/01/2007 - "Collectively, these results provide evidence that natural IgM and the early components of the classical pathway of complement work in concert to neutralize influenza virus and that this interaction may have a significant impact on the course of influenza viral pneumonia." Order ALL the reference details at left...
3.	Muramidase (Lysozyme)IBA 01/01/1984 - "Marked decrease in the content of complement and beta-lysins, elevation of the level of lysozyme were observed in patients with viral-bacterial and viral pneumonias as compared to the same characteristics in patients with bacterial pneumonia and in control group subjects." Order ALL the reference details at left...
4.	C-Reactive ProteinIBA 01/01/2000 - "Whether serum C-reactive protein (CRP) can be used to distinguish bacterial from viral pneumonia was studied in 193 paediatric patients who were identified in a prospective, population-based study. " 03/01/1978 - "Value of the C-reactive protein test in the differentiation of bacterial and viral pneumonia." 07/01/2000 - "Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children." 07/01/2000 - "OBJECTIVE: Serum procalcitonin (PCT), C-reactive protein (CRP) and interleukin-6 (IL-6) concentrations were measured in 126 children hospitalized for community-acquired, radiologically confirmed pneumonia to assess whether these host response values could be used to distinguish bacterial from viral pneumonia. " Order ALL the reference details at left...
5.	Antiviral Agents (Antivirals)IBA 03/01/1995 - "In the past few years, new diagnostic tests and a number of effective antiviral agents have been introduced; this makes the rapid diagnosis and treatment of viral pneumonia possible." 09/01/1987 - "Spectrum of activity, dosage, adverse reaction, and cost of the approved antiviral drugs useful in viral pneumonia is presented." 09/01/1987 - "The development of antiviral drugs is changing the specific treatment of viral pneumonias. " 11/01/2004 - "Since no randomized controlled trials have been conducted on the treatment of viral pneumonia by antivirals or immunomodulators in immunocompetent adults, a review of such anecdotal experience are needed for the more rational use of such agents. " Order ALL the reference details at left...
6.	4-ipomeanolIBA 02/01/1987 - "The effects of the pulmonary toxicant, 4-ipomeanol (4-IP), on Sendai viral pneumonia was examined in young adult female C57BL/6J mice. " 09/01/1991 - "The objectives of this study were to determine whether calves are susceptible to 4-ipomeanol-induced enhancement of parainfluenza type 3 viral pneumonia and to determine whether 4-ipomeanol alters pulmonary replication of parainfluenza virus. " Order ALL the reference details at left...
7.	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/20/1995 - "Seventeen patients in the cyclosporine group and 12 patients in the placebo group were withdrawn from the study; 2 patients in the cyclosporine group died, 1 from viral pneumonia and the other in a motor vehicle accident. " Order ALL the reference details at left...
8.	Vitamin A (Retinol)FDA Link 05/01/2000 - "We thus examined the effect of three interventions on viral pneumonia: 1) a high level vitamin A [250,000 IU/kg diet or 75,000 retinol equivalents (RE)/kg], or 2) control diet (4000 IU/kg diet or 1200 RE/kg) given before and during infection, and 3) initiating the high level diet upon infection to simulate the adjuvant therapy used in clinical trials. " 05/01/2000 - "This change in the Th1/Th2 pattern was not sufficient to affect recovery from viral pneumonia but may account for the increased IgA and decreased IgG responses seen with high level dietary vitamin A in this study. " Order ALL the reference details at left...
9.	Immunologic Factors (Immunomodulators)IBA 11/01/2004 - "Since no randomized controlled trials have been conducted on the treatment of viral pneumonia by antivirals or immunomodulators in immunocompetent adults, a review of such anecdotal experience are needed for the more rational use of such agents. " Order ALL the reference details at left...
10.	Immunoglobulin G (IgG)IBA 05/01/2000 - "This change in the Th1/Th2 pattern was not sufficient to affect recovery from viral pneumonia but may account for the increased IgA and decreased IgG responses seen with high level dietary vitamin A in this study. " Order ALL the reference details at left...

Therapies and Procedures

1.	Transplants (Transplant) 10/01/2006 - "MATERIALS AND METHODS: The study population consisted of 26 recipients of hematopoietic stem cell transplants who had proven respiratory viral pneumonia. " 05/01/2003 - "Five patients were not evaluable (NE) for response because of NED at transplant (n=2) or early death due to transplant-related complications (n=3) (two of viral pneumonia and one of regimen-related toxicity) occurring at a median of 4 days (range 11-46) post-transplant. " 03/27/1994 - "Bacterial and viral pneumonias were the major causes of late graft failure in both groups. " 03/01/1990 - "Viral pneumonia in recipients of solid organ transplants." 04/01/2007 - "The 2nd and 3rd month post transplant are mainly complicated by viral pneumonia, especially respiratory virus and adenovirus pneumonia in deeply immunosuppressed patients. " Order ALL the reference details at left...
2.	Transplantation (Transplant Recipients) 12/01/2006 - "STUDY DESIGN: A total of 220 BAL specimens from lung transplant recipients and other patients with suspected viral pneumonia were studied. " 12/01/2005 - "Viral pneumonias other than cytomegalovirus in transplant recipients." 03/01/2006 - "In conclusion: (i) about 50% of respiratory tract infections of lung transplant recipients were associated with one or more respiratory viruses; (ii) hMPV largely predominates in bronchoalveolar lavage of symptomatic lung transplant recipients, thus suggesting a causative role in lower respiratory tract infections; (iii) RT-PCR appears to be the method of choice for detection of respiratory viruses in lung transplant recipients, (iv) a high HCMV load in bronchoalveolar lavage is a risk factor for viral pneumonia, suggesting some measure of intervention for the control of viral infection." 09/01/2000 - "In this review, we describe a case of influenza viral pneumonia in an adult liver transplant recipient, review basic and clinical aspects of influenza infection in this patient population, and discuss current modes of prevention and treatment in detail." 04/01/1999 - "Patients were grouped into 7 categories based on their diagnosis: sepsis or sepsis syndrome (n = 3), bacterial or fungal pneumonia (n = 10), viral pneumonia (n = 5), trauma or burn (n = 2), inhalation injury without burn (n = 1), immunocompromised state (due to transplantation or chemotherapy) (n = 8), and acute respiratory failure of unknown origin (n = 5). " Order ALL the reference details at left...
3.	Immunotherapy 06/01/2004 - "BACKGROUND: To study apoptosis of peripheral blood cells of children with viral pneumonia, explore immunopathogenesis and the possibility of immunotherapy of patients with viral pneumonia. " Order ALL the reference details at left...
4.	Extracorporeal Membrane Oxygenation (ECMO) 11/01/2004 - "CONCLUSIONS: Venovenous extracorporeal membrane oxygenation allows time for the recovery of acute hypoxic insult and resolution of some viral pneumonia processes. " 08/01/2008 - "We present 2 pediatric cases of adenoviral pneumonia in patients who survived after greater than 30 days on ECMO and review the Extracorporeal Life Support Organization (ELSO) registry to describe the collective experience of children with viral pneumonia requiring prolonged ECMO. " 08/01/1992 - "Nine patients (41%) survived ECMO, with eight long-term survivors, (4 hydrocarbon aspiration or injection, 1 pulmonary contusion, 1 viral pneumonia, 1 ARDS, 1 barotrauma), three of whom have mild neurological deficit. " 06/01/2003 - "ECMO also resulted in survival of patients with uncommon conditions, including severe asthma (1), hydrocarbon aspiration (1/2), congestive heart failure due to a cerebral arteriovenous malformation (1), tracheal occlusion incurred during endoscopic stent manipulation (2), meningitis (1), and viral pneumonia (3/5). " Order ALL the reference details at left...
5.	Bronchoscopes 02/01/2000 - "Each of six calves inoculated endobronchially with bovine herpesvirus 1 (BHV-1) by means of a bronchoscope developed viral pneumonia. " 11/01/1993 - "Pigs inoculated endobronchially (EB) with 2 ml of virus suspension containing 10(4) TCID50 per ml of the YS-81 strain of pseudorabies virus (PRV), by means of a bronchoscope, all developed viral pneumonia. " Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Viral Pneumonia

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 3 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>